DOXEPIN HYDROCHLORIDE
- Product NDC
- 51672-4220
- 11-digit product format
- 516724220
- Labeler code
- 51672
- Product ID
- 51672-4220_f71ace15-9ee2-4547-88fa-f787496b7dc5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA213063
- Marketing category
- ANDA
- Marketing start
- 2020-07-01
- Marketing end
- 0000-00-00
- Substance
- DOXEPIN HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-4220 | DOXEPIN HYDROCHLORIDE CAPSULE [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Legacy NDC | 20200707_e5f35807-3db1-4387-8c37-693d9170b51b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-4220-1 | 51672422001 | 100 CAPSULE in 1 BOTTLE (51672-4220-1) | 100 capsule | 2020-07-01 | 0000-00-00 | No | No | Current |